Clinical Trial

A Phase II Clinical Study of SYH2068 Injection in Adults With Elevated Lipoprotein(a)

Name: A Phase II Clinical Study of SYH2068 Injection in Adults With Elevated Lipoprotein(a) — clinical trial record (NCT07640217)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

The purpose of this study is to evaluate the efficacy and safety of SYH2068 injection in patients with elevated lipoprotein(a).

Trial Details

NCT Number	NCT07640217
Lead Sponsor	CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.
Conditions	Adult Participants With Elevated Lipoprotein(a)
Enrollment	120 participants
Start Date	2026-07-30
Primary Completion	2028-03-30 (estimated)
Study Completion	2028-09-30 (estimated)
Updated on ClinicalTrials.gov	2026-06-10